Cargando…
Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report
Mixed autonomic hyperactivity disorder (MAHD) among patients with acquired brain injury can be rare. A delayed diagnosis of MAHD might exacerbate the clinical outcome and increase healthcare expenses with unnecessary testing. However, MAHD is still an underrecognized and evolving disease entity. A 2...
Autores principales: | Kang, Seong Hee, Kim, Min Ja, Shin, Il Young, Park, Dae Won, Sohn, Jang Wook, Yoon, Young Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410249/ https://www.ncbi.nlm.nih.gov/pubmed/22876068 http://dx.doi.org/10.3346/jkms.2012.27.8.965 |
Ejemplares similares
-
Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017) -
Uncontrolled central hyperthermia by standard dose of bromocriptine: A case report
por: Ge, Xin, et al.
Publicado: (2020) -
Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013) -
Effectively managing intractable central hyperthermia in a stroke patient by bromocriptine: a case report
por: Yu, Kuo-Wei, et al.
Publicado: (2013) -
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)